MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia.
- DOI
- 10.3389/falgy.2025.1726096
- Published
- 2025
- Container
- Frontiers in allergy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/falgy.2025.1726096,
title = {MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia.},
author = {Galeas-Pena M and Lyons JJ and Llivichuzhca-Loja D and Everman S and Yaghi G and White K and Sutradhar S and Robinson TO and Owings AH and Dhaliwal NS and Carlye A and Konnikova L and Ali H and Glover SC},
year = {2025},
journal = {Frontiers in allergy},
doi = {10.3389/falgy.2025.1726096},
url = {https://doi.org/10.3389/falgy.2025.1726096}
}RIS
TY - JOUR TI - MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia. AU - Galeas-Pena M AU - Lyons JJ AU - Llivichuzhca-Loja D AU - Everman S AU - Yaghi G AU - White K AU - Sutradhar S AU - Robinson TO AU - Owings AH AU - Dhaliwal NS AU - Carlye A AU - Konnikova L AU - Ali H AU - Glover SC PY - 2025 JO - Frontiers in allergy DO - 10.3389/falgy.2025.1726096 UR - https://doi.org/10.3389/falgy.2025.1726096 ER -
APA
M, G., JJ, L., D, L., S, E., G, Y., K, W., S, S., TO, R., AH, O., NS, D., A, C., L, K., H, A., & SC, G. (2025). MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia.. Frontiers in allergy. https://doi.org/10.3389/falgy.2025.1726096
Source records
- pubmed · retrieved 2026-09-26T13:15:58.087Z